Loading…

Loading grant details…

Completed PROJECT GRANT Swedish Research Council

Implexion Pharma - Preparation for clinical development of new pharmaceutical strategies for fibrosis diseases

3.17M kr SEK

Funder Vinnova
Recipient Organization Implexion Pharma Ab
Country Sweden
Start Date Nov 17, 2022
End Date Dec 31, 2023
Duration 409 days
Number of Grantees 1
Roles Principal Investigator
Data Source Swedish Research Council
Grant ID 2022-02166_Vinnova
Grant Description

Purpose and goal:

The purpose of this project has been to carry out preparatory steps that facilitate Implexion´s path to clinical studies, with objective of increasing the company´s patient understanding, developing a clinical plan, strengthening the organization and preparing for capitalization. The company has made progress in all areas and is now much better equipped to take on the next step towards clinical studies.

Expected results and effects: ** Denna text är maskinöversatt **

The results from the project means, just as expected, that Implexion is now ready for the next stage of development in the company´s progress towards clinical studies. The company now has a better understanding of the patient perspective, the design of remaining studies and requested results from investors and is ready with an organization that is even better suited to take the company forward.

Approach and implementation: ** Denna text är maskinöversatt **

The design and implementation of the project has worked well, but it has taken somewhat longer than what was expected when the application was submitted.

All Grantees

Implexion Pharma Ab

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant